AUSTRALIAN CENTRE FOR CANNABINOID CLINICAL AND RESEARCH EXCELLENCE (ACRE): QUALITY AND SAFETY IN THE IMPLEMENTATION OF MEDICINAL CANNABIS USE IN THE COMMUNITY

Abstract

Australia has a world-first opportunity to develop rigorous medical cannabis research based on quality clinical and environmental science that tests and selects cannabis constituents affecting health and sickness. It will be able to design and coordinate dose and formulation-finding studies to assess safety and efficacy of different cannabinoids. This information will enable registration of products for health that have been thoroughly researched and tested to levels acceptable for public use.